Resumen
Introduction: Real-life adherence to the management of heart failure is suboptimal. Adherence to the recommendations for the use of sacubitril/valsartan in Colombia is unknown. Objective: To assess the frequency of use, geographic distribution, and demo-graphic characteristics of patients who were prescribed sacubitril/valsartan in 2019-2020, using data from the “Sistema Integrado de Información de Protección Social” (SISPRO). Materials and method: This is a descriptive cross-sectional study. Information was extracted on the prescription distribution by department, gender, five-year age groups and the ICD-10 codes with which the medication was prescribed. Results: Between 2019 and 2020, 23,026 patients in Colombia were prescribed sacubitril/valsartan; 63.86% of the patients were men. Ninety-two percent of the prescriptions were for patients over the age of 50. The regions of the country with the highest prescription frequency were Bogotá, Sucre and Santander. Conclusions: Taking into account the estima-ted prevalence of heart failure (2-3%), the frequency with which sacubitril/valsartan is prescribed in Colombia is lower than expec-ted. The rural regions of the country have the lowest use, which suggests access barriers that should be explored.
Título traducido de la contribución | Frequency and geographical distribution of the use of sacubitril/valsartan in Colombia between 2019 and 2020 |
---|---|
Idioma original | Español |
Páginas (desde-hasta) | 12-18 |
Número de páginas | 7 |
Publicación | Revista Colombiana de Cardiologia |
Volumen | 31 |
N.º | 1 |
DOI | |
Estado | Publicada - 01 ene. 2024 |
Palabras clave
- Colombia
- Heart failure
- Sacubitril/valsartan